As AMD progresses, bioinformatics analyses have revealed a dynamic a shift in gene expression profiles, particularly toward pathways involved in angiogenesis (e.g., upregulation of VEGFA and HTRA1), lipid metabolism (APOE, ABCA1), and cellular senescence (CDKN2A). This evidence concerns the gene APOE and age-related macular degeneration.